Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32335 | 109 | 43.1 | 87% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2311 | 4082 | URETHRAL STRICTURE//URETHROPLASTY//TRANSURETHRAL RESECTION OF PROSTATE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HALOFUGINONE | Author keyword | 18 | 40% | 33% | 36 |
| 2 | MRI MRS HBRC | Address | 3 | 50% | 5% | 5 |
| 3 | CLUSTER PROJECT | Address | 2 | 67% | 2% | 2 |
| 4 | HEMODYNAMIC RESPONSE IMAGING | Author keyword | 1 | 100% | 2% | 2 |
| 5 | ANTI ANGIOGENETIC | Author keyword | 1 | 50% | 1% | 1 |
| 6 | BONE MARROW TRANSPLANTAT CANC IMMUNOBIOL | Address | 1 | 50% | 1% | 1 |
| 7 | EQUIPE ELLISEE LIGUE CANC 2012 | Address | 1 | 50% | 1% | 1 |
| 8 | LILIANE BETTENCOURT | Address | 1 | 50% | 1% | 1 |
| 9 | MICROBIAL PATHOGENESIS PROGRAM | Address | 1 | 50% | 1% | 1 |
| 10 | PROTEOGLICANOS MATRIZ EXTRACELULAR | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HALOFUGINONE | 18 | 40% | 33% | 36 | Search HALOFUGINONE | Search HALOFUGINONE |
| 2 | HEMODYNAMIC RESPONSE IMAGING | 1 | 100% | 2% | 2 | Search HEMODYNAMIC+RESPONSE+IMAGING | Search HEMODYNAMIC+RESPONSE+IMAGING |
| 3 | ANTI ANGIOGENETIC | 1 | 50% | 1% | 1 | Search ANTI+ANGIOGENETIC | Search ANTI+ANGIOGENETIC |
| 4 | PROTO ONCOGENE PROTEIN C MET | 1 | 50% | 1% | 1 | Search PROTO+ONCOGENE+PROTEIN+C+MET | Search PROTO+ONCOGENE+PROTEIN+C+MET |
| 5 | PLANT ALKALOID | 1 | 19% | 3% | 3 | Search PLANT+ALKALOID | Search PLANT+ALKALOID |
| 6 | COLLAGEN ALPHA 1I | 1 | 22% | 2% | 2 | Search COLLAGEN+ALPHA+1I | Search COLLAGEN+ALPHA+1I |
| 7 | HUMAN BREAST ADIPOSE TISSUE | 0 | 33% | 1% | 1 | Search HUMAN+BREAST+ADIPOSE+TISSUE | Search HUMAN+BREAST+ADIPOSE+TISSUE |
| 8 | MMP 2 EXPRESSION | 0 | 33% | 1% | 1 | Search MMP+2+EXPRESSION | Search MMP+2+EXPRESSION |
| 9 | VESSEL COOPTION | 0 | 33% | 1% | 1 | Search VESSEL+COOPTION | Search VESSEL+COOPTION |
| 10 | DICHROA FEBRIFUGA | 0 | 20% | 1% | 1 | Search DICHROA+FEBRIFUGA | Search DICHROA+FEBRIFUGA |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | I SYNTHESIS | 24 | 57% | 26% | 28 |
| 2 | COCCIDIOSTAT HALOFUGINONE | 6 | 80% | 4% | 4 |
| 3 | ALPHA1I GENE | 1 | 50% | 1% | 1 |
| 4 | AVIAN SKIN FIBROBLASTS | 1 | 50% | 1% | 1 |
| 5 | CANCER ASSOCIATED ADIPOCYTES | 1 | 50% | 1% | 1 |
| 6 | COCCIDIOSTAT | 0 | 20% | 2% | 2 |
| 7 | ANTI COCCIDIAL DRUG | 0 | 25% | 1% | 1 |
| 8 | EIF2 KINASE GCN2 | 0 | 25% | 1% | 1 |
| 9 | ANTICANCER DRUG TARGETS | 0 | 14% | 1% | 1 |
| 10 | HUMAN TUMOR OXYGENATION | 0 | 13% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Halofuginone - The Multifaceted Molecule | 2015 | 0 | 102 | 42% |
| Targeting TGF beta signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone | 2008 | 3 | 85 | 35% |
| Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract | 2014 | 0 | 86 | 31% |
| Halofuginone: A novel antifibrotic therapy | 1998 | 64 | 51 | 14% |
| Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma | 2003 | 1 | 63 | 25% |
| The tumor microenvironment: a critical determinant of neoplastic evolution | 2003 | 126 | 98 | 4% |
| Validating cancer drug targets | 2006 | 81 | 48 | 2% |
| Stromal responses in human primary melanoma of the skin | 2005 | 11 | 102 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MRI MRS HBRC | 3 | 50% | 4.6% | 5 |
| 2 | CLUSTER PROJECT | 2 | 67% | 1.8% | 2 |
| 3 | BONE MARROW TRANSPLANTAT CANC IMMUNOBIOL | 1 | 50% | 0.9% | 1 |
| 4 | EQUIPE ELLISEE LIGUE CANC 2012 | 1 | 50% | 0.9% | 1 |
| 5 | LILIANE BETTENCOURT | 1 | 50% | 0.9% | 1 |
| 6 | MICROBIAL PATHOGENESIS PROGRAM | 1 | 50% | 0.9% | 1 |
| 7 | PROTEOGLICANOS MATRIZ EXTRACELULAR | 1 | 50% | 0.9% | 1 |
| 8 | RADIOL ETUD GENOME | 1 | 50% | 0.9% | 1 |
| 9 | BMT CBB | 0 | 33% | 0.9% | 1 |
| 10 | MRS HBRC | 0 | 33% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000127286 | FEBRIFUGINE//PIPERIDINES//CONHYDRINE |
| 2 | 0.0000118945 | PANCREATIC STELLATE CELLS//PANCREATIC FIBROSIS//PANCREATIC STELLATE CELL |
| 3 | 0.0000111109 | SYSTEMIC SCLEROSIS//SCLERODERMA//TIGHT SKIN MOUSE |
| 4 | 0.0000102067 | PRL 3//PHOSPHATASE OF REGENERATING LIVER 3//PRL 1 |
| 5 | 0.0000089091 | HEPATIC STELLATE CELLS//HEPATIC STELLATE CELL//LIVER FIBROSIS |
| 6 | 0.0000087455 | LARP6//ALPHA 2I COLLAGEN//DERIVATIVE OF ERYTHROMYCIN |
| 7 | 0.0000079348 | MINERAL NUTR//ZINC METHIONINE//TETRABASIC ZINC CHLORIDE |
| 8 | 0.0000072187 | HEPARANASE//CANC VASC BIOL//PI 88 |
| 9 | 0.0000064818 | 3 HYDROXYPYRIDINE AND SUCCINIC ACID DERIVATIVES//COMBINED INJURIES//CEREBROPROTECTIVE EFFECT |
| 10 | 0.0000063031 | ADHESIONS//ADHESION PREVENTION//ADHESION FORMATION |